Istesso

Istesso is a biotechnology company focused on drug discovery and development within the field of immunometabolism. Founded in 2017, it serves as the holding company for Modern Biosciences Ltd. The company specializes in creating therapies aimed at reprogramming metabolism to address autoimmune and inflammatory diseases, particularly rheumatoid arthritis and multiple sclerosis. Istesso's pipeline includes both pre-clinical and clinical assets designed to provide disease-resolving solutions for chronic conditions, enhancing the ability of healthcare professionals to effectively diagnose and treat these disorders.